Opin vísindi

Fletta eftir höfundi "Drobnjak, Tijana"

Fletta eftir höfundi "Drobnjak, Tijana"

Röðun: Raða: Niðurstöður:

  • Icon
    Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits 
    Drobnjak, Tijana; Meiri, Hamutal; Mandalá, Maurizio; Huppertz, Berthold; Gizurarson, Sveinbjorn (Dove Medical Press Ltd., 2018-07)
    Introduction: Human placental protein 13 (PP13) is a galectin predominantly expressed by the placenta. Low serum concentrations of PP13 in early pregnancy indicate a higher risk of developing preeclampsia. Methods: The pharmacokinetic disposition ...
  • Icon
    Physiological and pharmacokinetic properties of Placental Protein 13 (PP13) In vivo and in vitro studies in animals 
    Drobnjak, Tijana (University of Iceland, School of Health Sciences, Faculty of Pharmaceutical Sciences, 2018)
    Inngangur: Þegar kona verður þunguð, eiga sér stað miklar breytingar á æðakerfi hennar, til að mæta aukinni blóðþörf til fylgju og fósturs og tryggja eðlilegan vöxt fóstursins. Til að þetta sé hægt, þarf stækkun á æðum sem flytja blóð til fóstursins ...
  • Icon
    Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration 
    Drobnjak, Tijana; Jónsdóttir, Anna Margrét; Helgadottir, Helga; Runólfsdóttir, Margrét Soffía; Meiri, Hamutal; Sammar, Marei; Osol, George J.; Mandalà, Maurizio; Huppertz, Berthold; Gizurarson, Sveinbjorn (Informa UK Limited, 2019-03-27)
    Introduction: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications ...